Media Centre
Latest press releases
-
Voydeya recommended for approval in the EU by CHMP as add-on treatment to ravulizumab or eculizumab for adults with PNH who have residual haemolytic anaemia
-
Acquisition of Gracell completed
-
Acquisition of Icosavax Completed
-
Tagrisso with the addition of chemotherapy approved in the US for patients with EGFR-mutated advanced lung cancer
-
Datopotamab deruxtecan Biologics License Application accepted in the US for patients with previously treated advanced nonsquamous non-small cell lung cancer
Medical Releases
These press releases are specifically for health specialist/medical media and are not for consumer press.